SED will execute the design, engineering, equipment supply, erection and commissioning of the sugar crystallization section on an accelerated timeline,…
Read MoreBusiness Micro
News Stories
Anime India to Host Landmark Mumbai Convention with Naruto Director Hayato Date and 50,000 Fans at NESCO
Mumbai, Aug 24: Anime India, the premier platform bridging Japanese pop culture and Indian fandom, is officially launching the country’s…
Read MoreZoomcar and Uber partner to give travelers more ways to plan road trips
Now compare self-drive and chauffeur-driven Intercity options within the Zoomcar app BENGALURU, India and NEW YORK, Aug. 24, 2026 /PRNewswire/…
Read MoreKonark Set to Celebrate Five-Day Jhulana Utsav With Classical Arts
Konark, Aug 24: The historic town of Konark is preparing to come alive with music, dance and cultural traditions as…
Read MoreWYF Brings Together 400+ Students for Future Liberal Arts Leadership Summit in Macao
MACAU, Aug. 24, 2026 /PRNewswire/ — World Youth Forum (WYF), an international nonprofit platform engaging 500,000+ young people annually across…
Read MoreOdisha Steps Up Urban Development Drive with Focus on Clean Cities and Better Civic Services
Bhubaneswar, Aug 24: The Odisha government has reiterated its focus on building cleaner, safer and better-planned cities while improving housing,…
Read MoreNew US$22 Million Education Lifeline for Crisis-Affected Children in Sudan
New three-year investment will reach nearly 200,000 crisis-affected children and adolescents, helping them return to safe, inclusive learning while supporting…
Read MoreIBM and the USTA Introduce New AI-Powered Fan Experiences for 2026 US Open
NEW YORK, Aug. 24, 2026 /PRNewswire/ — IBM (NYSE: IBM) and the United States Tennis Association (USTA) today announced new…
Read MorePhilanthropy Activates Campus-Wide Opportunities
Aug 24: With its new innovative pledges for student readiness and experiential learning, renowned distinction in teaching and research, and…
Read MoreAnbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication Expansion
TAIPEI, Aug. 24, 2026 /PRNewswire/ — Anbogen Therapeutics Inc. (TPEx: 7784) (“Anbogen” or the “Company”), a clinical-stage precision oncology company,…
Read More